Detalhe da pesquisa
1.
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
N Engl J Med
; 389(15): 1390-1401, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754204
2.
Cefiderocol: Clinical application and emergence of resistance.
Drug Resist Updat
; 72: 101034, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134561
3.
Impact of pH on the activity of novel cephalosporin cefiderocol in human urine.
J Antimicrob Chemother
; 79(1): 166-171, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000090
4.
Aetiology and use of antibiotics in pregnancy-related infections: results of the WHO Global Maternal Sepsis Study (GLOSS), 1-week inception cohort.
Ann Clin Microbiol Antimicrob
; 23(1): 21, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402175
5.
Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci.
Clin Infect Dis
; 77(9): 1273-1281, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345869
6.
Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Clin Infect Dis
; 77(Suppl 1): S97-S103, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406042
7.
Exploring Cefiderocol Resistance Mechanisms in Burkholderia pseudomallei.
Antimicrob Agents Chemother
; 67(6): e0017123, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133377
8.
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-ß-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
Antimicrob Agents Chemother
; 67(8): e0066323, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395652
9.
Successful Use of Cefepime-Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-ß-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
Antimicrob Agents Chemother
; : e0050023, 2023 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314343
10.
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study.
Antimicrob Agents Chemother
; 67(8): e0040523, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404159
11.
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program.
Antimicrob Agents Chemother
; 67(7): e0019423, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347188
12.
Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections.
Curr Opin Infect Dis
; 36(2): 89-94, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853762
13.
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives.
Curr Opin Infect Dis
; 36(6): 615-622, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846592
14.
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Curr Opin Infect Dis
; 36(6): 564-571, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930070
15.
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
J Antimicrob Chemother
; 78(9): 2254-2262, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527369
16.
Comparison of prophylactic antibiotics for endonasal transsphenoidal surgery using a national inpatient database in Japan.
J Antimicrob Chemother
; 78(12): 2909-2914, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856687
17.
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
J Antimicrob Chemother
; 78(11): 2752-2761, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807834
18.
Simultaneous and divergent evolution of resistance to cephalosporin/ß-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
J Antimicrob Chemother
; 78(5): 1195-1200, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918743
19.
Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations.
Br J Clin Pharmacol
; 89(9): 2726-2738, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005335
20.
In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.
Pharm Res
; 40(7): 1789-1797, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253866